Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

primary myelofibrosis News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report details a rare synchronous triple malignancy involving multiple myeloma, prefibrotic primary myelofibrosis, and mucinous breast carcinoma in a patient from rural South Africa. This unique presentation highlights the complexity of managing multiple rare cancers simultaneously.

Recent research highlights the role of calreticulin mutations in essential thrombocythemia and primary myelofibrosis, providing insights into the molecular mechanisms underlying these conditions. Understanding these mutations could lead to improved diagnostic and therapeutic strategies.

A case report highlights a breakthrough invasive Aspergillus granulosus infection in a patient with primary myelofibrosis after azole antifungal therapy. This finding underscores the potential complications of antifungal treatments in immunocompromised patients.

The MPN PROGRESSion Registry is launched to track symptoms, treatments, and disease progression in individuals with myeloproliferative neoplasms (MPNs). This observational study aims to enhance understanding of conditions like Polycythemia Vera and Essential Thrombocythemia.

Not rare diseases news,news about your rare disease.

Earlier

A case report details a rare synchronous triple malignancy involving multiple myeloma, prefibrotic primary myelofibrosis, and mucinous breast carcinoma in a patient from rural South Africa. This unique presentation highlights the complexity of managing multiple rare cancers simultaneously.

Recent research highlights the role of calreticulin mutations in essential thrombocythemia and primary myelofibrosis, providing insights into the molecular mechanisms underlying these conditions. Understanding these mutations could lead to improved diagnostic and therapeutic strategies.

A case report highlights a breakthrough invasive Aspergillus granulosus infection in a patient with primary myelofibrosis after azole antifungal therapy. This finding underscores the potential complications of antifungal treatments in immunocompromised patients.

The MPN PROGRESSion Registry is launched to track symptoms, treatments, and disease progression in individuals with myeloproliferative neoplasms (MPNs). This observational study aims to enhance understanding of conditions like Polycythemia Vera and Essential Thrombocythemia.

Not rare diseases news,
news about your rare disease.